Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke S Howard

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Echo Research and Practice|July 18, 2018
Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of EchocardiographyDaniel X Augustine, Lindsay D Coates-Bradshaw, James Willis, et al.
The Lancet. Respiratory Medicine|June 19, 2017
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort studyChristopher J Rhodes, John Wharton, Pavandeep Ghataorhe, et al.
Circulation|February 8, 2014
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertensionBeata Wojciak-Stothard, Vahitha B Abdul-Salam, Ka Hou Lao, et al.
Plos One|April 5, 2021
Reusable snorkel masks adapted as particulate respiratorsHenry Seligman, Sameer Zaman, David S Pitcher, et al.
Plos One|September 1, 2021
Correction: Reusable snorkel masks adapted as particulate respiratorsHenry Seligman, Sameer Zaman, David S Pitcher, et al.
Circulation|August 1, 2013
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatmentsLan Zhao, Ali Ashek, Lei Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
Frontiers in Cardiovascular Medicine|January 2, 2023
The thromboxane receptor antagonist <i>NTP42</i> promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overloadEamon P Mulvaney, Fabiana Renzo, Rui Adão, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Echo Research and Practice|July 18, 2018
Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of EchocardiographyDaniel X Augustine, Lindsay D Coates-Bradshaw, James Willis, et al.
The Lancet. Respiratory Medicine|June 19, 2017
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort studyChristopher J Rhodes, John Wharton, Pavandeep Ghataorhe, et al.
Circulation|February 8, 2014
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertensionBeata Wojciak-Stothard, Vahitha B Abdul-Salam, Ka Hou Lao, et al.
Plos One|April 5, 2021
Reusable snorkel masks adapted as particulate respiratorsHenry Seligman, Sameer Zaman, David S Pitcher, et al.
Plos One|September 1, 2021
Correction: Reusable snorkel masks adapted as particulate respiratorsHenry Seligman, Sameer Zaman, David S Pitcher, et al.
Circulation|August 1, 2013
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatmentsLan Zhao, Ali Ashek, Lei Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
Frontiers in Cardiovascular Medicine|January 2, 2023
The thromboxane receptor antagonist <i>NTP42</i> promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overloadEamon P Mulvaney, Fabiana Renzo, Rui Adão, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Pageof 12